Recent Price Movement and Market Context
On 27 Jan 2026, Shalby Ltd. touched an intraday low of Rs.160.75, representing a decline of 2.31% on the day. The stock has been on a losing streak for two consecutive sessions, resulting in a cumulative loss of 6.7% over this period. This underperformance is notable against the hospital sector, where Shalby lagged by 1.77% today. The stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum.
Meanwhile, the broader market environment has been subdued. The Sensex opened lower at 81,436.79, down 100.91 points (-0.12%), and is currently trading marginally down at 81,529.93 (-0.01%). The Sensex itself has been on a three-week losing streak, shedding 2.45% in that timeframe. Several indices, including NIFTY MEDIA and NIFTY REALTY, also hit new 52-week lows today, indicating a cautious market sentiment.
Long-Term and Recent Performance Metrics
Over the last year, Shalby Ltd. has delivered a negative return of 23.85%, significantly underperforming the Sensex, which gained 8.18% during the same period. The stock’s 52-week high was Rs.274.50, underscoring the extent of the decline from its peak. This underperformance extends beyond the last year, with Shalby lagging the BSE500 index over the past three years, one year, and three months.
Just announced: This Small Cap from Tyres & Allied with precise target price is our pick for the week. Get the pre-market insights that informed this selection!
- - Just announced pick
- - Pre-market insights shared
- - Tyres & Allied weekly focus
Financial Performance and Ratios
Shalby Ltd.’s financial results have reflected subdued growth. The company reported flat results in the September 2025 quarter. Its profit after tax (PAT) for the nine months ended September 2025 stood at Rs.6.29 crores, representing a steep decline of 82.36% compared to the previous period. This significant contraction in profitability has contributed to the stock’s weak performance.
The company’s return on capital employed (ROCE) for the half year was recorded at 6.10%, the lowest in recent periods, indicating limited efficiency in generating returns from its capital base. The debt-equity ratio has increased to 0.53 times, the highest level observed, suggesting a modest rise in leverage. Despite this, Shalby maintains a relatively low Debt to EBITDA ratio of 1.18 times, signalling a strong ability to service its debt obligations.
Valuation and Market Perception
Shalby Ltd. currently holds a Mojo Score of 40.0 with a Mojo Grade of Sell, downgraded from Hold as of 1 Dec 2025. The market capitalisation grade stands at 3, reflecting its mid-tier size within the hospital sector. Domestic mutual funds hold no stake in the company, which may indicate limited institutional confidence or interest at prevailing price levels.
The stock is trading at a discount relative to its peers’ average historical valuations. With a ROCE of approximately 5 and an enterprise value to capital employed ratio of 1.5, the valuation metrics suggest an attractive price point compared to sector averages. However, this valuation has not translated into positive returns, as the company’s profits have declined by 91.8% over the past year.
Sector and Market Comparisons
Within the hospital sector, Shalby Ltd.’s performance contrasts with broader market trends. While the Sensex and other indices have shown resilience or modest declines, Shalby’s stock has consistently underperformed. The sector itself has experienced volatility, with some indices hitting 52-week lows today, but Shalby’s decline is more pronounced in both absolute and relative terms.
Why settle for Shalby Ltd.? SwitchER evaluates this Hospital small-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Summary of Key Metrics
To encapsulate, Shalby Ltd.’s stock has declined to Rs.160.75, its lowest level in 52 weeks, following a series of financial setbacks and market pressures. The stock’s one-year return of -23.85% contrasts sharply with the Sensex’s positive 8.18% gain. Profitability has contracted sharply, with PAT down 82.36% in the latest nine-month period and a 91.8% drop in profits over the past year. The company’s ROCE remains subdued at 6.10%, while leverage has increased moderately.
Despite these challenges, the company maintains a manageable debt servicing profile and trades at a valuation discount relative to peers. However, the absence of domestic mutual fund holdings and the downgrade to a Sell grade reflect prevailing market caution. The stock’s position below all major moving averages further underscores the current bearish sentiment.
Market Outlook and Broader Implications
Shalby Ltd.’s recent price action and financial indicators highlight the pressures faced by mid-sized hospital sector companies in a competitive and evolving healthcare landscape. The stock’s underperformance relative to broader indices and sector peers suggests that investors are factoring in the company’s recent earnings trends and valuation metrics. The broader market’s cautious tone, with multiple indices hitting 52-week lows and the Sensex on a three-week decline, adds to the challenging environment for stocks like Shalby.
While the company’s fundamentals show areas of concern, such as declining profitability and subdued returns on capital, its ability to service debt and valuation discount remain notable features. These factors contribute to a complex investment profile amid a cautious market backdrop.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
